How Much Glutathione To Take: Biomarker-Guided Dosing for Metabolic Health

Last reviewed: May 29, 2026

Last updated: May 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Glutathione dosing in clinical practice typically ranges from 250 to 1500 mg daily, depending on route of administration, individual health status, and therapeutic intent. The wide range reflects variability in absorption, individual antioxidant burden, and metabolic demands across different patient populations.

Determining the right glutathione dose for your specific situation requires understanding your baseline oxidative stress markers, metabolic profile, and how your genetics influence antioxidant pathway function. PlexusDx supports precision-wellness conversations by connecting genetic insights with clinical dosing frameworks.

Oral vs. Intravenous Glutathione: Dosing Differs by Route

Oral glutathione absorption is notoriously poor, with most studies showing only 5–15% bioavailability due to rapid degradation in the gastrointestinal tract. Typical oral doses range from 500–1500 mg daily in divided doses to account for this limitation.

Intravenous glutathione bypasses absorption barriers and is used clinically at doses of 600–2400 mg per administration, often once or twice weekly. The choice of route fundamentally shapes dosing strategy and should align with your provider's assessment of your specific health needs and oxidative stress markers.

Dosing Framework by Clinical Context and Biomarker Status

Glutathione dosing should account for baseline oxidative stress, antioxidant capacity, and individual metabolic factors. This table outlines common dosing ranges and the clinical contexts in which they are typically recommended, based on current evidence and provider protocols.

Clinical Context	Typical Daily Dose (Oral)	Typical IV Dose	Biomarker Consideration
General antioxidant support	500–750 mg	600–1200 mg weekly	Baseline oxidative stress markers
Athletic recovery / sports performance	750–1000 mg daily	1200–1500 mg weekly	Post-exercise ROS and inflammation
Detoxification support	1000–1500 mg daily	1500–2400 mg weekly	Liver function and phase II enzyme status
Chronic disease management	500–1200 mg daily	1200–2000 mg weekly	Disease-specific biomarkers and GSH depletion

Individual Factors That Influence Optimal Dosing

Age, sex, baseline health status, and genetic predisposition all affect how your body processes and utilizes glutathione. Older adults and those with compromised antioxidant systems may require lower starting doses with gradual titration based on tolerance and biomarker response.

Medications, existing liver or kidney disease, and concurrent supplement use can alter glutathione metabolism and efficacy. Your provider should review your complete medical history and relevant biomarkers—such as liver function tests, oxidative stress markers, and antioxidant enzyme activity—before recommending a specific dose.

Safety Considerations and When Provider Guidance Is Essential

Glutathione is generally well-tolerated, but excessive supplementation may cause gastrointestinal upset, headaches, or rarely allergic reactions. Starting with lower doses and monitoring for adverse effects is a standard, cautious approach before adjusting upward based on clinical response.

Patients with certain conditions—including asthma (where glutathione may interact with bronchial function), kidney disease, or those taking chemotherapy—should only use glutathione under direct provider supervision. A qualified healthcare provider should interpret your biomarkers and health history to determine whether glutathione supplementation is appropriate and what dose is safe.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context on your individual antioxidant pathway function by examining genetic variants related to glutathione synthesis and metabolism. Understanding these predispositions can support a more informed conversation with your provider about whether standard dosing ranges align with your unique metabolic profile.

The genetic test reveals predispositions in key pathways—such as glutathione S-transferase (GST) activity and cysteine availability—that influence how efficiently your body produces and utilizes glutathione. This information should be interpreted with a qualified healthcare provider and does not predict exact glutathione response or eliminate the need for biomarker monitoring.

By combining genetic insights with clinical biomarkers (oxidative stress markers, antioxidant enzyme activity, liver function), you and your provider can make a more personalized dosing decision within evidence-based ranges. This precision-wellness approach may help optimize your glutathione strategy and support more targeted health outcomes.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the safest starting dose of glutathione for most people?

Most providers recommend starting with 250–500 mg daily (oral) and monitoring tolerance for 1–2 weeks before increasing. A qualified healthcare provider should assess your individual health status and biomarkers before recommending your specific starting dose.

How long does it take to see results from glutathione supplementation?

Clinical effects vary widely. Some biomarkers (oxidative stress, antioxidant capacity) may shift within 2–4 weeks, while functional improvements may take 8–12 weeks or longer depending on dose, route, and baseline status.

Can I take glutathione every day, or should I cycle it?

Daily glutathione use is common in clinical practice, though some providers recommend cycling (e.g., 5 days on, 2 days off) to prevent adaptation. Your provider should guide this based on your biomarkers and health goals.

Is oral glutathione as effective as intravenous glutathione?

IV glutathione achieves higher blood levels due to better bioavailability, but oral forms may still benefit some individuals. Route choice depends on your clinical goals and your provider's assessment of your oxidative stress markers and access.

How does the Precision Peptide Genetic Test relate to glutathione dosing?

The test reveals genetic predispositions in antioxidant pathways that may help inform whether you're more or less dependent on exogenous glutathione support. These insights should be combined with biomarker data and clinical evaluation to guide dosing conversations with your provider.